495 related articles for article (PubMed ID: 19919601)
1. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
5. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
Chang TK; Chen J; Benetton SA
Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.
Sparfel L; Van Grevenynghe J; Le Vee M; Aninat C; Fardel O
Carcinogenesis; 2006 Mar; 27(3):656-63. PubMed ID: 16258175
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells.
Rajaraman G; Yang G; Chen J; Chang TK
Can J Physiol Pharmacol; 2009 Sep; 87(9):674-83. PubMed ID: 19794518
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic analysis of cDNA-expressed human CYP1A1, CYP1A2, and CYP1B1 with 7-ethoxyresorufin as substrate.
Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():85-90. PubMed ID: 16719376
[TBL] [Abstract][Full Text] [Related]
11. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
[TBL] [Abstract][Full Text] [Related]
12. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver.
Chang TK; Chen J; Pillay V; Ho JY; Bandiera SM
Toxicol Sci; 2003 Jan; 71(1):11-9. PubMed ID: 12520071
[TBL] [Abstract][Full Text] [Related]
13. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
14. Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.
Uno S; Dragin N; Miller ML; Dalton TP; Gonzalez FJ; Nebert DW
Free Radic Biol Med; 2008 Feb; 44(4):570-83. PubMed ID: 17997381
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
16. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice.
Shimada T; Inoue K; Suzuki Y; Kawai T; Azuma E; Nakajima T; Shindo M; Kurose K; Sugie A; Yamagishi Y; Fujii-Kuriyama Y; Hashimoto M
Carcinogenesis; 2002 Jul; 23(7):1199-207. PubMed ID: 12117779
[TBL] [Abstract][Full Text] [Related]
17. For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential.
Dragin N; Dalton TP; Miller ML; Shertzer HG; Nebert DW
J Biol Chem; 2006 Jul; 281(27):18591-600. PubMed ID: 16636061
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
[TBL] [Abstract][Full Text] [Related]
20. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
